Stockscreener 앱 받기
0.17
1.51%
-0.0026
전일 마감가:
$0.1726
열려 있는:
$0.166
하루 거래량:
3.65M
Relative Volume:
3.56
시가총액:
$14.25M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-0.2024
EPS:
-0.84
순현금흐름:
$-47.97M
1주 성능:
+28.59%
1개월 성능:
-47.74%
6개월 성능:
-67.62%
1년 성능:
-91.19%
1일 변동 폭
$0.163
$0.1991
1주일 범위
$0.1253
$0.1991
52주 변동 폭
$0.1253
$2.50
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
0.17 | 14.25M | 361.07M | -71.54M | -47.97M | -0.84 |
|
HCA
Hca Healthcare Inc
|
325.47 | 83.32B | 69.62B | 5.93B | 5.88B | 20.33 |
|
THC
Tenet Healthcare Corp
|
141.98 | 13.97B | 20.97B | 3.13B | 2.39B | 4.33 |
|
DVA
Davita Inc
|
165.63 | 13.81B | 12.67B | 827.68M | 1.42B | 5.03 |
|
UHS
Universal Health Services Inc
|
203.50 | 13.34B | 15.42B | 1.03B | 956.84M | 9.53 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.48 | 13.16B | 20.87B | 715.14M | 1.67B | 0.8156 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
Oncology Institute Inc 주식(TOI)의 최신 뉴스
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Yahoo Finance
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Oncology Institute Reports Third Quarter 2024 Financial Results - The Manila Times
Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan
Oncology Institute Announces Board Changes for 2025 - TipRanks
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times
Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
Cancer Care - WellSpan Health
Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute - RWJBarnabas Health
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute - PR Newswire
Verismo Therapeutics Announces the Activation of its CELESTIAL-301 Clinical Trial at Colorado Blood Cancer Institute - PR Newswire
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Indian Oil Corp. shares up 0.76% as Nifty gains - The Economic Times
The Oncology Institute appoints new CFO - Investing.com
Oncology Institute Announces CFO Transition and Strategic Growth Plan - TipRanks
The Oncology Institute Announces CFO Transition - GlobeNewswire
Cardinal Health to acquire Integrated Oncology Network for $1.12B - HealthLeaders Media
Ionis Plans $500M Public Offering - San Diego Business Journal
Itau Unibanco Holding S.A. Buys Shares of 767 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Renaissance Technologies LLC Purchases 69,800 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
ORIX Co. (NYSE:IX) Shares Purchased by American Century Companies Inc. - Defense World
DRW Securities LLC Makes New $2.43 Million Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
Victory Capital Management Inc. Sells 307 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Granite Investment Partners LLC Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion By Reuters - Investing.com
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
0.25%
자본화:
|
볼륨(24시간):